Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Bone Marrow Transplantation|September 12, 2007
Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphomaJ G Kim, S K Sohn, Y S Chae, et al.
Journal of Vascular Surgery|June 4, 2002
A multicenter experience with the Talent endovascular graft for the treatment of abdominal aortic aneurysmsPeter L Faries, Bruce J Brener, Timothy L Connelly, et al.
Bone Marrow Transplantation|March 2, 2010
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onsetJ H Moon, S N Kim, B W Kang, et al.
British Journal of Cancer|January 24, 2008
Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology GroupJ G Kim, S K Sohn, Y S Chae, et al.
Journal of Ethnopharmacology|February 13, 2001
Inhibitory action of water soluble fraction of Terminalia chebula on systemic and local anaphylaxisT Y Shin, H J Jeong, D K Kim, et al.
Genome Research|November 15, 2000
BodyMap: a collection of 3' ESTs for analysis of human gene expression informationS Kawamoto, J Yoshii, K Mizuno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trialR Dent, Z Shao, P Schmid, et al.
Oncogene|February 1, 2011
Downregulation of Spry2 by miR-21 triggers malignancy in human gliomasH-J Kwak, Y-J Kim, K-R Chun, et al.
ESMO Open|July 8, 2026
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapiesJ W Kim, Y H Park, S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2026
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY TrialG M Kim, K H Jung, H C Jeung, et al.
Pageof 20